Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancer
Long-term dynamic ctDNA monitoring after pancreatic cancer resection, particularly following the completion of ACT, is predictive of recurrence risk. The proactive implementation of ctDNA monitoring after ACT in patients with resectable pancreatic cancer has important implications for clinical practice.
Authors
- Jiani C. Yin
- Fufeng Wang (ORCID: https://orcid.org/0000-0002-8933-4909)
- Yaru Liu (ORCID: https://orcid.org/0000-0003-3178-6352)
- Xiangbo Kong (ORCID: https://orcid.org/0000-0003-1183-0459)
- X. H. Bai (ORCID: https://orcid.org/0009-0006-9737-2880)
- Lu Zou (ORCID: https://orcid.org/0009-0008-2354-6002)
- Fanyan Meng (ORCID: https://orcid.org/0009-0001-4717-8506)
- Jiayao Ni (ORCID: https://orcid.org/0009-0004-4845-3006)
- Huizi Sha
- Fan Tong
- Juan Du
- Haochen Tang
Institutions
- Nanjing Drum Tower Hospital (CN)
- Genesee Community College (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3389/fonc.2026.1745466
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- National Natural Science Foundation of China